Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: A nationwide prescription-level analysis

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 10, 2013, Pages 2383-2392

  Blommaert, Adriaan ^a   Coenen, Samuel ^a   Gielen, Birgit ^b   Goossens, Herman ^a   Hens, Niel ^a,c   Beutels, Philippe ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Intermutualistic Agency (IMA/AIM)   (Belgium)

^c HASSELT UNIVERSITY   (Belgium)

Author keywords

Ambulatory care; Antibiotics; Belgium; GEEs; Pharmaceuticals

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; MOXIFLOXACIN;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BELGIUM; CHILD; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; GROUPS BY AGE; HUMAN; LOWEST INCOME GROUP; MALE; OUTPATIENT CARE; PATIENT PREFERENCE; PEDIATRICIAN; POPULATION; PRESCHOOL CHILD; PRESCRIPTION; REIMBURSEMENT; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE; SOCIAL ASPECT;

AMBULATORY CARE; ANTIBIOTICS; BELGIUM; GEES; PHARMACEUTICALS;

ADULT; AMBULATORY CARE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BELGIUM; CHILD, PRESCHOOL; DRUG UTILIZATION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS;

EID: 84888794126     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt170     Document Type: Article

References (28)

1. Malhotra-Kumar S, Lammens C, Coenen S et al. Impact of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci among healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007; 369: 482-90.
2. Costelloe C, Metcalfe C, Lovering A et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010; 340: c2096.
3. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002; 8: 347-54.
4. Opatowski L, Guillemot D, Boelle PY et al. Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Curr Opin Infect Dis 2011; 24: 279-87.
5. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
6. Gyssens IC. Quality measures of antimicrobial drug use. Int J Antimicrob Agents 2001; 17: 9-19.
7. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
8. European Surveillance of Antimicrobial Consumption (ESAC); outpatient antibiotic consumption (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi1-94.
9. Huttner B, Goossens H, Verheij T et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010; 10: 17-31.
10. Coenen S, Costers M, De Corte S et al. The first European Antibiotic Awareness Day after a decade of improving outpatient antibiotic use in Belgium. Acta Clin Belg 2008; 63: 296-300.
11. Goossens H, Coenen S, Costers M et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill 2008; 13: pii=19036.
12. Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother 2007; 59: 537-43.
13. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of outpatient antibiotic use in Europe. J Antimicrob Chemother 2011; 66 Suppl 6: vi71-7.
14. Chevalier P, De Sutter A, Meyer A et al. Belgische gids voor antiinfectieuze behandeling in de ambulante praktijk. 2nd edn. BAPCOC: Brussels, 2008.
15. Schokkaert E, Van de Voorde C. Health care reform in Belgium. Health Econ 2005; 14 Suppl 1: S25-39.
16. Schokkaert E, Van Ourti T, De Graeve D et al. Supplemental health insurance and equality of access in Belgium. Health Econ 2010; 19: 377-95.
17. WHO. Guidelines for ATC Classification and DDD Assignment. 2011. http://www.whocc.no/filearchive/publications/2011guidelines.pdf (20 January 2013, date last accessed).
18. Adriaenssens N, Coenen S, Versporten A et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother 2011; 66 Suppl 6: vi47-56.
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
20. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-30.
21. Miglioretti DL, Heagerty PJ. Marginal modeling of nonnested multilevel data using standard software. Am J Epidemiol 2007; 165: 453-63.
22. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics 2001; 57: 120-5.
23. Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA 2003; 289: 719-25.
24. Grigoryan L, Burgerhof JGM, Degener JE et al. Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother 2008; 61: 1172-9.
25. Mangione-Smith R, McGlynn EA, Elliott MN et al. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999; 103: 711-8.
26. Avorn J, Solomon DH. Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med 2000; 133: 128-35.
27. Coenen S, Michiels B, Renard D et al. Antibiotic prescribing for acute cough: the effect of perceived patient demand. Br J Gen Pract 2006; 56: 183-90.
28. Lopez-Vazquez P, Vazquez-Lago JM, Figueiras A. Misprescription of antibiotics in primary care: a critical systematic review of its determinants. J Eval Clin Pract 2012; 18: 473-84.